33rd Annual Meeting

NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016

Thursday-Friday, June 16-17, 2016

Conference Location:

MEMORIAL SLOAN KETTERING CANCER CENTERRockefeller Research Laboratories430 67th Street, New York, NY, 10065

MSK sets a new standard for outpatient cancer surgery with the opening of the Josie Robertson Surgery Center.

Course DirectorsWilliamJ. Schneider, MD, MPHAttending Physician in MedicineMemorial Sloan Kettering Cancer Center

Stephen R. Veach, MDAttending PhysicianThoracic Oncology ServiceMemorial Sloan Kettering Cancer Center

Theodore J. Kowalski, MDCorporate Health Director of JP Morgan Chase & Co. External Liaison Director of the NCMA

33rd Annual MeetingNATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016

The 33rd annual conference will provide National Corporate Medical Associates members with a comprehensive overview of treatment advances for cancer patients featuring a faculty of experts from MSK.

You must be a National Corporate Medical Associates member to register for this activity.

Registration for this event will be emailed to all NCMA members. If you did not receive an email, please contact cme@mskcc.org.

Thursday, June 16, 2016

8:00-9:00am BREAKFAST

9:00-9:05am IntroductionWilliam J. Schneider, MD, MPH and Stephen R. Veach, MD

9:05-9:15am WelcomePhilip Kantoff, MD

9:15-9:45am Prostate CancerPhilip Kantoff, MD

9:45-10:15am Colon Cancer ScreeningRobin Mendelsohn, MD

10:15-10:45am Immunologic Checkpoint Blockade: Exploring Combinations and MechanismsJedd D. Wolchok, MD, PhD

10:45-11:15am COFFEE BREAK

11:15-11:30am Breast Cancer Radiation: New IndicationsBeryl McCormick, MD, FACR

11:30-12:00pm Exercise and CancerLee W. Jones, MD

12:00-12:15pm NCMA DevelopmentsPANEL: Reya Sinha, Theodore J. Kowalski, MD, Stephen Veach, MD and William J. Schneider, MD, MPH

12:15-1:45pm LUNCH SESSIONJosie Robertson Surgical CenterBrett A. Simon, MD, PhD

1:45-2:15pm Treatment of Actinic Keratoses: How My Patients Scare Away Children and Small AnimalsAllan C. Halpern, MD

2:15-3:00pm The Dilemma of Oncology Drug Costs Leonard B. Saltz, MD

3:00-3:30pm Infections with the Zika, Dengue and Chikungunya VirusesMonika K. Shah, MD

3:30-3:45pm COFFEE BREAK

3:45-4:15pm MSK’s Survivorship ProgramStacie Corcoran, NP

4:15-4:45pm Developments in the Management of Multiple MyelomaAlexander M. Lesokhin, MD

4:45-5:00pm ANNOUNCEMENTS

Registration for this event will be emailed to all NCMA members. If you did not receive an email, please contact cme@mskcc.org.

Friday, June 17, 2016

8:00-9:00am BREAKFAST

9:00-9:30am Developments in the Treatment of LymphedemaBabak J. Mehrara, MD

9:30-10:00am Mitigating the Potential Side-Effects of Radiotherapy for G-U CancerMarisa A. Kollmeier, MD

10:00-10:30am What’s New in Breast Cancer: ASCO Update, Triple Negative Breast Cancer and Beyond Tiffany A. Traina, MD

10:30-10:45am COFFEE BREAK

10:45-11:15am Smoking Cessation StrategiesJack E. Burkhalter, MD

11:15-11:45am What’s New in Breast Cancer: ASCO Update, Endocrine therapy and HER2+Maura Dickler, MD

11:45-12:00pm CONCLUSING COMMENTSTheodore J. Kowalski, MD

NCMA physician members are invited to attend a special evening event on Thursday, June 16, 2016:

6:00pm - DinnerPlaywright Celtic Pub & Restaurant

732 8th Avenue, New York, NY

8:00pm - CAGNEY the Musical Westside Theatre

407 W 43rd Street, New York, NY

*Please note: Thursday evening events are reserved for NCMA physician members only.*Shuttle transportation will be provided to dinner only.

MSK Faculty

Jack E. Burkhalter, PhDPsychologist

Stacie Corcoran, NPNurse Leader, Surviorship Clinic

Maura Dickler, MDAssociate Attending PhysicianActing Service Chief, Breast Medicine ServiceSection Head, Endocrine Therapy Clinical Research Program Associate Professor, Weill Cornell Medicine

Allan C. Halpern, MDInternist & Dermatologist;Chief, Dermatology Service

Lee W. Jones, PhDExercise Scientist

Philip Kantoff, MDChair, Department of Medicine;George J. Bosl Chair

Marisa A. Kollmeier, MDRadiation Oncologist

Alexander M. Lesokhin, MDHematologic Oncologist

Beryl McCormick, MD, FACRRadiation Oncologist;Chief, External Beam Radiotherapy Service, Manhattan

Babak J. Mehrara, MDPlastic & Reconstructive Surgery

Robin Mendelsohn, MDGastroenterologist

Leonard B. Saltz, MDMedical Oncologist;Chief, Gastrointestinal Oncology Service;Head, Colorectal Oncology Section

Monika K. Shah, MDInfectious Disease Specialist;Vice Chair, Education, Department of Medicine

Brett A. Simon, MD, PhDAnesthesiologist;Director of MSK’s Josie Roberston Surgery Center

Reya SinhaDirector, Office of the Physician-in-Chief

Tiffany A. Traina, MDAssociate Attending PhysicianClinical Director, Breast Medicine ServiceSection Head, Triple Negative Breast Cancer Clinical Research Program Assistant Professor, Weill Cornell Medicine

Jedd A. Wolchok, MD, PhDLloyd J Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation;Chief, Melanoma & Immunotherapeutics Service;Associate Director, Ludgwig Center for Cancer Immunotherapy

Accreditation StatementMSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AccommodationsFor information on hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/accommodations.

Faculty DisclosureIt is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

EvaluationA course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.

RegistrationRegistration for this event will be emailed to all NCMA members. If you did not receive an email, please contact the office of Continuing Medical Education at cme@mskcc.org.

MSK designates this live activity for a maximum of 9.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 9.0 AMA PRA Category 1 Credit(s)TM.

AMA Credit Designation Statement